TrendingVideosIndia
Opinions ▾
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC ▾
UPSC | Exam ScheduleExam Mentor
State ▾
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City ▾
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World ▾
World | ChinaUnited StatesPakistan
Diaspora
Features ▾
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business ▾
Business | My MoneyAutoZone
News Columns ▾
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement
Home / India / Icmr Threatens Legal Action Over Bhu Study On Covaxin Side Effects 623220

ICMR threatens legal action over BHU study on Covaxin side-effects

Tribune News Service
Updated At : 12:11 PM May 21, 2024 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Aksheev Thakur

Advertisement

Advertisement

New Delhi, May 20

Days after a Banaras Hindu University (BHU) study reported long-term “adverse events of special interest (AESI)” in a group of over 926 persons a year after they were administered Bharat Biotech’s Covaxin, the Indian Council of Medical Research (ICMR) on Monday called it a “poorly designed study with critical flaws” and threatened researchers with legal consequences for wrongly acknowledging the institute as a partner in the study.

The ICMR said the study had no control group of unvaccinated individuals to prove that the side-effects were only associated with vaccination.

Advertisement

Published in journal Springer Nature, the study has stated that new-onset skin and subcutaneous disorders, general disorders, and nervous system disorders are common AESIs in adolescents. The ICMR listed four critical flaws in the study.

Advertisement
Tags :
Bharat

Suggested Articles

Show comments
Advertisement
Advertisement

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Copyright © The Tribune Trust, 2024
Designed and developed by :  SORTD